Robion Ag

Click Here To EMAIL INQUIRY
Contact: Jurgen Lutcke
Web: http://www.robion.ch
E-Mail:
Address: 6 Gewerbestrasse, Neuhausen Am Rheinfall, Sh 8212, Switzerland
Phone: +41-(52)-6700 955 | Fax: +41-(52)-6700 968 | Map/Directions >>

Profile: Robion Ag produces high-complexity analyzer systems for clinical diagnostics applications. We specialize in the assembly & supply of highly complex clinical diagnostics analyzer systems which are used for the benefit of patients.

The company was founded in 2005, has ~30 employees and is ISO 13485:2003 certified.

3 Products/Services (Click for related suppliers)

• Discrete Photometric Chemistry Analyzer (FDA Code: JJE / 862.2160)

A discrete photometric chemistry analyzer for clinical use is a device intended to duplicate manual analytical procedures by performing automatically various steps such as pipetting, preparing filtrates, heating, and measuring color intensity. This device is intended for use in conjunction with certain materials to measure a variety of analytes. Different models of the device incorporate various instrumentation such as micro analysis apparatus, double beam, single, or dual channel photometers, and bichromatic 2-wavelength photometers. Some models of the device may include reagent-containing components that may also serve as reaction units.

• Labeled Medical Laboratory Equipment (FDA Code: LXG / 862.2050)

General purpose laboratory equipment labeled or promoted for a specific medical use is a device that is intended to prepare or examine specimens from the human body and that is labeled or promoted for a specific medical use.

• Tumor Antigen Immunological Test System (FDA Code: MOI / 866.6010)

A tumor-associated antigen immunological test system is a device that consists of reagents used to qualitatively or quantitatively measure, by immunochemical techniques, tumor-associated antigens in serum, plasma, urine, or other body fluids. This device is intended as an aid in monitoring patients for disease progress or response to therapy or for the detection of recurrent or residual disease.